C4 therapeutics to participate in upcoming march investor conferences

Watertown, mass., feb. 24, 2021 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced that the company will participate in the following upcoming march investor conferences:
CCCC Ratings Summary
CCCC Quant Ranking